DÄ internationalArchive13/2020The diagnosis and treatment of glaucoma


The diagnosis and treatment of glaucoma

Dtsch Arztebl Int 2020; 117: 225-34. DOI: 10.3238/arztebl.2020.0225

Schuster, A K; Erb, C; Hoffmann, E M; Dietlein, T; Pfeiffer, N

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Augenklinik und Poliklinik, Universitätsmedizin Mainz: Prof. Dr. med. Alexander K. Schuster, Prof. Dr. med. Esther M. Hoffmann, Prof. Dr. med. Norbert Pfeiffer
Privatinstitut für angewandte Augenheilkunde Berlin: Prof. Dr. med. Carl Erb
Universitätsaugenklinik Köln: Prof. Dr. med. Thomas Dietlein
1.Leffler CT, Schwartz SG, Giliberti FM, et al.: What was glaucoma called before the 20th century? Ophthalmol Eye Dis 2015; 7: 21–33 CrossRef MEDLINE PubMed Central
2.Weinreb RN, Aung T, Medeiros FA: The pathophysiology and treatment of glaucoma: a review. JAMA 2014; 311: 1901–11 CrossRef MEDLINE PubMed Central
3.Jonas JB, Aung T, Bourne RR, et al.: Glaucoma. Lancet 2017; 390: 2183–93 CrossRef
4.Tian H, Li L, Song F: Study on the deformations of the lamina cribrosa during glaucoma. Acta Biomater 2017; 55: 340–8 CrossRef MEDLINE
5.Shoji T, Kuroda H, Suzuki M, et al.: Glaucomatous changes in lamina pores shape within the lamina cribrosa using wide bandwidth, femtosecond mode-locked laser OCT. PLoS One 2017; 12: e0181675 CrossRef MEDLINE PubMed Central
6.Erb C: Functional disorders in the chronological progression of glaucoma. Ophthalmologe 2015; 112: 402–9 CrossRef MEDLINE
7.Okafor K, Vinod K, Gedde SJ: Update on pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol 2017; 28: 154–60 CrossRef MEDLINE
8.Miglior S, Bertuzzi F: Exfoliative glaucoma: new evidence in the pathogenesis and treatment. Prog Brain Res 2015; 221: 233–41 CrossRef MEDLINE
9.Chan MP, Grossi CM, Khawaja AP, et al.: Associations with intraocular pressure in a large cohort: results from the UK Biobank. Ophthalmology 2016; 123: 771–82 CrossRef MEDLINE PubMed Central
10.Sales CS, Lee RY, Agadzi AK, et al.: Open-angle glaucoma in Filipino and white Americans: a comparative study. J Glaucoma 2014; 23: 246–53 CrossRef MEDLINE
11.Heijl A, Leske MC, Bengtsson B, et al.: Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 2002; 120: 1268–79 CrossRef MEDLINE
12.Barbosa-Breda J, Van Keer K, Abegao-Pinto L, et al.: Improved discrimination between normal-tension and primary open-angle glaucoma with advanced vascular examinations – the Leuven Eye Study. Acta Ophthalmol 2019; 97: e50–6 CrossRef MEDLINE
13.Pillunat KR, Spoerl E, Jasper C, et al.: Nocturnal blood pressure in primary open-angle glaucoma. Acta Ophthalmol 2015; 93: e621–6 CrossRef MEDLINE
14.Bourne RR, Taylor HR, Flaxman SR, et al.: Number of people blind or visually impaired by glaucoma worldwide and in world regions 1990 – 2010: a meta-analysis. PLoS One 2016; 11: e0162229 CrossRef MEDLINE PubMed Central
15.Bourne RRA, Jonas JB, Bron AM, et al.: Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br J Ophthalmol 2018; 102: 575–85 CrossRef MEDLINE PubMed Central
16.Tham YC, Li X, Wong TY, et al.: Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014; 121: 2081–90 CrossRef MEDLINE
17.Höhn R, Nickels S, Schuster AK, et al.: Prevalence of glaucoma in Germany: results from the Gutenberg Health Study. Graefes Arch Clin Exp Ophthalmol 2018; 256: 1695–702 CrossRef MEDLINE
18.Schuster AK, Pfeiffer N, Nickels S, et al.: Steeper iris conicity is related to a shallower anterior chamber: The Gutenberg Health Study. J Ophthalmol 2017; 2017: 2190347 CrossRef MEDLINE PubMed Central
19.Kapetanakis VV, Chan MP, Foster PJ, et al.: Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol 2016; 100: 86–93 CrossRef MEDLINE PubMed Central
20.Marx-Gross S, Laubert-Reh D, Schneider A, et al.: The prevalence of glaucoma in young people. Dtsch Arztebl Int 2017; 114: 204–10 CrossRef MEDLINE PubMed Central
21.Ramdas WD, Wolfs RC, Hofman A, et al.: Ocular perfusion pressure and the incidence of glaucoma: real effect or artifact? The Rotterdam Study. Invest Ophthalmol Vis Sci 2011; 52: 6875–81 CrossRef MEDLINE
22.Ekstrom C: Risk factors for incident open-angle glaucoma: a population-based 20-year follow-up study. Acta Ophthalmol 2012; 90: 316–21 CrossRef MEDLINE
23.Le A, Mukesh BN, McCarty CA, et al.: Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 2003; 44: 3783–9 CrossRef MEDLINE
24.Czudowska MA, Ramdas WD, Wolfs RC, et al.: Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology 2010; 117: 1705–12 CrossRef MEDLINE
25.Nagaoka N, Jonas JB, Morohoshi K, et al.: Glaucomatous-type optic discs in high myopia. PLoS One 2015; 10: e0138825 CrossRef MEDLINE PubMed Central
26.Wang X, Rumpel H, Lim WE, et al.: Finite element analysis predicts large optic nerve head strains during horizontal eye movements. Invest Ophthalmol Vis Sci 2016; 57: 2452–62 CrossRef CrossRef
27.Jonas JB, Wang N, Yang D, et al.: Facts and myths of cerebrospinal fluid pressure for the physiology of the eye. Prog Retin Eye Res 2015; 46: 67–83 CrossRef MEDLINE
28.Kass MA, Heuer DK, Higginbotham EJ, et al.: The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701–13; discussion 829–30 CrossRef MEDLINE
29.Zhao D, Cho J, Kim MH, et al.: The association of blood pressure and primary open-angle glaucoma: a meta-analysis. Am J Ophthalmol 2014; 158: 615–27.e9 CrossRef MEDLINE
30.Zhou M, Wang W, Huang W, et al.: Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS One 2014; 9: e102972 CrossRef MEDLINE PubMed Central
31.Shi Y, Liu P, Guan J, et al.: Association between glaucoma and obstructive sleep apnea syndrome: a meta-analysis and systematic review. PLoS One 2015; 10: e0115625 CrossRef MEDLINE PubMed Central
32.Jonas JB, Holbach L: Central corneal thickness and thickness of the lamina cribrosa in human eyes. Invest Ophthalmol Vis Sci 2005; 46: 1275–9 CrossRef MEDLINE
33.Goldmann H, Schmidt T: Applanation tonometry. Ophthalmologica 1957; 134: 221–42 CrossRef MEDLINE
34.Harper CL, Boulton ME, Bennett D, et al.: Diurnal variations in human corneal thickness. Br J Ophthalmol 1996; 80: 1068–72 CrossRef MEDLINE PubMed Central
35.Hoffmann EM, Prokosch-Willing V: Primary open angle glaucoma. Klin Monbl Augenheilkd 2017; 234: 1407–22 CrossRef MEDLINE
36.Crabb DP, Smith ND, Glen FC, et al.: How does glaucoma look?: Patient perception of visual field loss. Ophthalmology 2013; 120: 1120–6 CrossRef MEDLINE
37.Kim KE, Kim MJ, Park KH, et al.: Prevalence, awareness, and risk factors of primary open-angle glaucoma: Korea National Health and Nutrition Examination Survey 2008–2011. Ophthalmology 2016; 123: 532–41 CrossRef MEDLINE
38.Heijl A, Bengtsson B, Oskarsdottir SE: Prevalence and severity of undetected manifest glaucoma: results from the early manifest glaucoma trial screening. Ophthalmology 2013; 120: 1541–5 CrossRef MEDLINE PubMed Central
39.Gramer G, Gramer E: Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability. Int Ophthalmol 2018; 38: 429–41 CrossRef MEDLINE
40.Berufsverband der Augenärzte Deutschlands e. V., Deutsche Ophthalmologische Gesellschaft e. V.: Leitlinie Nr. 15 c: Detektion des primären Offenwinkelglaukoms (POWG): Glaukom-Screening von Risikogruppen, Glaukomverdacht, Glaukomdiagnose. 2006.
e1.Vessani RM, Moritz R, Batis L, et al.: Comparison of quantitative imaging devices and subjective optic nerve head assessment by general ophthalmologists to differentiate normal from glaucomatous eyes. J Glaucoma 2009; 18: 253–61 CrossRef MEDLINE
e2.Abrams LS, Scott IU, Spaeth GL, et al.: Agreement among optometrists, ophthalmologists, and residents in evaluating the optic disc for glaucoma. Ophthalmology 1994; 101: 1662–7 CrossRef
e3.Jonas JB, Budde WM, Panda-Jonas S: Ophthalmoscopic evaluation of the optic nerve head. Surv Ophthalmol 1999; 43: 293–320 CrossRef
e4.Jonas JB, Budde WM: Diagnosis and pathogenesis of glaucomatous optic neuropathy: morphological aspects. Prog Retin Eye Res 2000; 19: 1–40 CrossRef
e5.Berufsverband der Augenärzte Deutschlands e. V., Deutsche Ophthalmologische Gesellschaft e. V.: Leitlinie Nr. 15 a: Primäres chronisches Offenwinkelglaukom, Normaldruckglaukom und okuläre Hypertension. 2006.
e6.Hoffmann EM, Miglior S, Zeyen T, et al.: The Heidelberg retina tomograph ancillary study to the European Glaucoma Prevention Study: study design and baseline factors. Acta Ophthalmol 2013; 91: e612–9 CrossRef MEDLINE
e7.Enders P, Adler W, Kiessling D, et al.: Evaluation of two-dimensional Bruch‘s membrane opening minimum rim area for glaucoma diagnostics in a large patient cohort. Acta Ophthalmol 2019; 97: 60–7 CrossRef MEDLINE
e8.Shin JW, Sung KR, Lee GC, et al.: Ganglion cell-inner plexiform layer change detected by optical coherence tomography indicates progression in advanced glaucoma. Ophthalmology 2017; 124: 1466–74 CrossRef MEDLINE
e9.European Glaucoma Society: Terminology and guidelines for glaucoma. PubliComm. 4th edition 2014.
e10.Garway-Heath DF, Crabb DP, Bunce C, et al.: Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 2015; 385: 1295–304 CrossRef
e11.Maier PC, Funk J, Schwarzer G, et al.: Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 2005; 331: 134 CrossRef MEDLINE PubMed Central
e12.Li T, Lindsley K, Rouse B, et al.: Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology 2016; 123: 129–40 CrossRef MEDLINE PubMed Central
e13.Gulati V, Fan S, Gardner BJ, et al.: Mechanism of action of selective laser trabeculoplasty and predictors of response. Invest Ophthalmol Vis Sci 2017; 58: 1462–8 CrossRef MEDLINE PubMed Central
e14.Lavia C, Dallorto L, Maule M, et al.: Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: asystematic review and meta-analysis. PLoS One 2017; 12: e0183142 CrossRef MEDLINE PubMed Central
e15.Gedde SJ, Feuer WJ, Shi W, et al.: Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 2018; 125: 650–63 CrossRef CrossRef MEDLINE
e16.Vass C, Hirn C, Sycha T, et al.: Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database Syst Rev 2007: Cd003167 CrossRef MEDLINE PubMed Central
e17.Alm A, Grierson I, Shields MB: Side effects associated with prostaglandin analog therapy. Surv Ophthalmol 2008; 53 (Suppl 1): 93–105 CrossRef MEDLINE
e18.Fudemberg SJ, Batiste C, Katz LJ: Efficacy, safety, and current applications of brimonidine. Expert Opin Drug Saf 2008; 7: 795–9 CrossRef MEDLINE
e19.Frech S, Kreft D, Guthoff RF, et al.: Pharmacoepidemiological assessment of adherence and influencing co-factors among primary open-angle glaucoma patients- an observational cohort study. PLoS One 2018; 13: e0191185 CrossRef MEDLINE PubMed Central
e20.Rouland JF, Traverso CE, Stalmans I, et al.: Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma. Br J Ophthalmol 2013; 97: 196–200 CrossRef MEDLINE
e21.Aquino MC, Barton K, Tan AM, et al.: Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol 2015; 43: 40–6 CrossRef MEDLINE
e22.Michelessi M, Bicket AK, Lindsley K: Cyclodestructive procedures for non-refractory glaucoma. Cochrane Database Syst Rev 2018; 4: Cd009313 CrossRef MEDLINE PubMed Central
e23.Malvankar-Mehta MS, Iordanous Y, Chen YN, et al.: iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a meta-analysis. PLoS One 2015; 10: e0131770 CrossRef MEDLINE PubMed Central
e24.Pillunat LE, Erb C, Junemann AG, et al.: Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin Ophthalmol 2017; 11: 1583–600 CrossRef MEDLINE PubMed Central
e25.Agrawal P, Bradshaw SE: Systematic literature review of clinical and economic outcomes of micro-invasive glaucoma surgery (MIGS) in primary open-angle glaucoma. Ophthalmol Ther 2018; 7: 49–73 CrossRef MEDLINE PubMed Central
e26.Cabourne E, Clarke JC, Schlottmann PG, et al.: Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev 2015: Cd006259 CrossRef MEDLINE
e27.Ederer F, Gaasterland DA, Dally LG, et al.: The advanced glaucoma intervention study (AGIS): 13. comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004; 111: 651–64 CrossRef MEDLINE
e28.Eldaly MA, Bunce C, Elsheikha OZ, et al.: Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma. Cochrane Database Syst Rev 2014: Cd007059 CrossRef MEDLINE
e29.Azuara-Blanco A, Burr J, Ramsay C, et al.: Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet 2016; 388: 1389–97 CrossRef
e30.Lowe RF: Primary angle-closure glaucoma. Prevention and early treatment. Isr J Med Sci 1972; 8: 1362–5 MEDLINE